Cardiovascular risk factors contribute to disparities in graft outcomes in African American renal transplant recipients: A retrospective analysis

References

• de Mattos AM, Prather J, Olyaei AJ, Shibagaki Y, Keith DS, Mori M, et al. Cardiovascular events following renal transplantation: Role of traditional and transplant-specific risk factors. Kidney Int. 2006;70:757–764.
   PubMed Web of Science ®Google Scholar
• Chakkera HA, O’Hare AM, Johansen KL, Hynes D, Stroupe K, Colin PM, et al. Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. J Am Soc Nephrol. 2005;16:269–277.
   PubMed Web of Science ®Google Scholar
• Hardinger KL, Stratta RJ, Egidi MF, Alloway RR, Shokouh-Amiri MH, Gaber LW, et al. Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era. Surgery. 2001;130:738–745; discussion 45–47.
   PubMed Web of Science ®Google Scholar
• Foster CE 3rd, Philosophe B, Schweitzer EJ, Colonna JO, Farney AC, Jarrell B, et al. A decade of experience with renal transplantation in African-Americans. Ann Surg. 2002;236: 794–804; discussion 805.
   PubMed Web of Science ®Google Scholar
• Light JA, Barhyte DY, Lahman L. Kidney transplants in African Americans and non-African Americans: Equivalent outcomes with living but not deceased donors. Transplant Proc. 2005;37:699–700.
   PubMed Web of Science ®Google Scholar
• Eckhoff DE, Young CJ, Gaston RS, Fineman SW, Deierhoi MH, Foushee MT, et al. Racial disparities in renal allograft survival: A public health issue? J Am Coll Surg. 2007;204:894–902; discussion 903.
   PubMed Web of Science ®Google Scholar
• Sam R, Leehey DJ. Improved graft survival after renal transplantation in the United States, 1988 to1996. N Engl J Med.2000;342:1837–1838.
   Google Scholar
• Axelrod DA, McCullough KP, Brewer ED, Becker BN, Segev DL, Rao PS. Kidney and pancreas transplantation in the United States, 1999-2008: The changing face of living donation.Am J Transplant.2010;10(4 Pt 2):987–1002.
   Google Scholar
• Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation. 2006;82:603–11.
   PubMed Web of Science ®Google Scholar
• Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to know? Where do we go from here? Special report from the National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis. 1998;32(5 Suppl 3):S1–199.
   PubMed Web of Science ®Google Scholar
• Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997;277: 1293–1298.
   PubMed Web of Science ®Google Scholar
• Fellstrom B. Risk factors for and management of post- transplantation cardiovascular disease. BioDrugs. 2001;15: 261–278.
   PubMed Web of Science ®Google Scholar
• Wright JT Jr., Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA. 2002; 288:2421–2431.
   PubMed Web of Science ®Google Scholar
• Humar A, Kerr SR, Ramcharan T, Gillingham KJ, Matas AJ. Peri-operative cardiac morbidity in kidney transplant recipients: Incidence and risk factors. Clin Transplant. 2001;15: 154–158.
   PubMed Web of Science ®Google Scholar
• Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int. 1998;53:217–222.
   PubMed Web of Science ®Google Scholar
• Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA. 2000;283: 633–638.
   PubMed Web of Science ®Google Scholar
• Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, et al. New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int. 2005;67:2415–2421.
   PubMed Web of Science ®Google Scholar
• Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM. Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney Int. 2002;62: 1440–1446.
   PubMed Web of Science ®Google Scholar
• Alexander GC, Sehgal AR. Barriers to cadaveric renal transplantation among blacks, women, and the poor. JAMA. 1998;280:1148–1152.
   PubMed Web of Science ®Google Scholar
• Kalil RS, Heim-Duthoy KL, Kasiske BL. Patients with a low income have reduced renal allograft survival. Am J Kidney Dis. 1992;20:63–69.
   PubMed Web of Science ®Google Scholar
• Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS. Kidney and pancreas transplantation in the United States, 1996-2005. Am J Transplant.2007;7(5 Pt 2): 1359–1375.
   Google Scholar
• Saseen JJ, MacLaughlin EJ, Westfall JM. Treatment of uncomplicated hypertension: Are ACE inhibitors and calcium channel blockers as effective as diuretics and beta-blockers? J Am Board Fam Pract. 2003;16:156–164.
   PubMedGoogle Scholar
• Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, et al. Preserving renal function in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis. 2000;36:646–661.
   PubMed Web of Science ®Google Scholar
• Lindholm LH, Ibsen H, Dahlof B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet. 2002;359:1004–1010.
   PubMed Web of Science ®Google Scholar
• Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, et al. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA. 2003;289:2073–2082.
   PubMed Web of Science ®Google Scholar
• Weir MR, Fink JC. Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34:1–13.
   PubMed Web of Science ®Google Scholar
• Kasiske BL. Cardiovascular disease after renal transplantation. Semin Nephrol. 2000;20:176–187.
   PubMed Web of Science ®Google Scholar
• Wissing KM, Abramowicz D, Broeders N, Vereerstraeten P. Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection. Transplantation. 2000;70:464–472.
   PubMed Web of Science ®Google Scholar
• Aakhus S, Dahl K, Wideroe TE. Cardiovascular morbidity and risk factors in renal transplant patients. Nephrol Dial Transplant. 1999;14:648–654.
   PubMed Web of Science ®Google Scholar
• Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, et al. Effects of statins in patients with chronic kidney disease: Meta-analysis and meta- regression of randomised controlled trials. BMJ. 2008;336: 645–651.
   PubMed Web of Science ®Google Scholar